Clinical Trial Update: A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program

View source ↗

Summary

A clinical trial update describing a study to learn more about treating congenital thrombotic thrombocytopenic purpura (cTTP) with recombinant ADAMTS13 in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Thrombotic Thrombocytopenic Purpura
• Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• Recombinant ADAMTS13 (ADAMTS13)

Snippet

Sponsor: Takeda | Conditions: Thrombotic Thrombocytopenic Purpura (TTP) | Status: NOT_YET_RECRUITING